000			01804nam a2200409Ia 4500
001			EBC3379028
003			MiAaPQ
005			20240121044047.0
006			m o d |
007			cr cn|||||||||
008			111220s2012 dcua sb 000 0 eng d
020			_z9780309253154
020			_z0309253152
035			_a(MiAaPQ)EBC3379028
035			_a(Au-PeEL)EBL3379028
035			_a(CaPaEBR)ebr10606369
035			_a(CaONFJC)MIL394882
035			_a(OCoLC)902942425
040			_aMiAaPQ _cMiAaPQ _dMiAaPQ
050		4	_aR853.C55 _bE585 2012
245	0	0	_aEnvisioning a transformed clinical trials enterprise in the United States _h[electronic resource] : _bestablishing an agenda for 2020: workshop summary / _cNeil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.
260			_aWashington : _bNational Academies Press, _c2012.
300			_axvi, 232 p. : _bill.
504			_aIncludes bibliographical references.
533			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650		0	_aClinical trials _zUnited States.
650		0	_aClinical medicine _xResearch _zUnited States.
655		4	_aElectronic books.
700	1		_aWeisfeld, Neil E.
700	1		_aEnglish, Rebecca A.
700	1		_aClaiborne, Anne B.
710	2		_aInstitute of Medicine (U.S.). _bForum on Drug Discovery, Development, and Translation.
710	2		_aInstitute of Medicine (U.S.). _bBoard on Health Sciences Policy.
710	2		_aNational Academies Press (U.S.)
710	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3379028 _zClick to View
999			_c206508 _d206508